KB Financial Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$7K Sell
92
-50
-35% -$4.19K ﹤0.01% 408
2023
Q2
$13K Sell
142
-7,804
-98% -$672K ﹤0.01% 381
2023
Q1
$641K Buy
7,946
+1,027
+15% +$83.7K 0.19% 64
2022
Q4
$538K Sell
6,919
-508
-7% -$41.2K 0.18% 75
2022
Q3
$600K Buy
7,427
+1,130
+18% +$102K 0.21% 58
2022
Q2
$565K Buy
6,297
+1,365
+28% +$138K 0.2% 56
2022
Q1
$547K Buy
4,932
+417
+9% +$44.1K 0.15% 67
2021
Q4
$467K Buy
4,515
+885
+24% +$102K 0.13% 83
2021
Q3
$455K Buy
3,630
+315
+10% +$40.8K 0.17% 72
2021
Q2
$411K Buy
3,315
+9
+0.3% +$1.13K 0.16% 72
2021
Q1
$391K Buy
+3,306
New +$387K 0.17% 56

Other funds holding MDT

KB Financial Partners's MDT Position: Q3 2023 in Review

KB Financial Partners reduced its Medtronic (MDT) stake by 35% in Q3 2023, selling an estimated $4.19K and leaving 92 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #408.

KB Financial Partners first reported a position in MDT in Q1 2021 and has held it in 11 quarters since. The position peaked at $641K in Q1 2023. 1,970 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

  • KB Financial Partners held 92 shares of Medtronic worth $7K as of Q3 2023.
  • KB Financial Partners sold 50 Medtronic shares in Q3 2023, an estimated $4.19K.
  • Medtronic made up ﹤0.01% of KB Financial Partners's portfolio in Q3 2023, its #408 holding.
  • KB Financial Partners first reported a position in Medtronic in Q1 2021 and has held it in 11 quarters since.
  • KB Financial Partners's Medtronic position peaked at $641K in Q1 2023.
  • 1,970 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.